GLP-1 drug costs cut roughly in half under Trump, Medicare director says
Center for Medicare Director Chris Klomp joins ‘Mornings with Maria’ to outline the Trump admin[……] Read More
GLP-1 weight loss disrupting fashion retail demand
When the size-inclusivity movement gained momentum, it revolutionized the fashion industry, pushing[……] Read More
Tom Brady says GLP-1 drugs are a ‘kick start,’ not a shortcut
eMed chief wellness officer Tom Brady and eMed CEO Linda Yaccarino discuss GLP-1 market growth[……] Read More
Aspen Pharmacare eyes Canada GLP-1 generic approval by September
Africa’s largest drugmaker expects to get approval in Canada for its ge[……] Read More